Although athymic nude mice are an established model for the maintenance of human xenografts in vivo (Sharkey et al., 1978) , they can exhibit a high incidence of malignant lymphomas (Custer et al., 1973) which may be associated with chronic antigen stimulation resulting in the activation of endogenous murine leukaemic viruses, MuLV, (Baird et al., 1982) . Also, xenotropic and ectopic MuLV can infect transplanted tumour cells (Hirsch et al., 1972; Todaro et al., 1973) and intact virions may be recovered from such tumours in vitro after passage in mice (Price et al., 1975) . These phenomena can become a serious problem in the routine handling of human tumours; either because the resulting tumour could become murine rather than human or because the addition of murine viral proteins to the complement of human cell proteins could complicate biochemical and immunological studies of the tumour as well as efforts to identify possible human retroviruses endogenous to a particular tumour.
At the Royal Marsden Hospital there is considerable interest in the biology and drug sensitivity of malignant myeloma. The human myeloma cell. line, RPMI-8226, (Matsuoko et al., 1967 ) is used routinely in our laboratory as a model for the disease and it was intended to establish these cells in vivo as a xenograft. Electron micrographs of the cells show that they are plasmablastoid with a well developed endoplasmic reticulum (Figure la) . They are hyperdiploid, exhibit lambda immunoglobulin on the cell surface as well as HAN PCI, which is characteristic of plasma cells (Mertens et al., 1985) , and have a doubling time of 40 h in vitro (Miller & Bell, 1987) .
RPMI-8226 cells are passaged in suspension . in RPMI-1640 supplemented with 15% foetal calf serum, 20mM HEPES buffer, 100IUml-I penicillin, and 100 pgml-l streptomycin. Initially an inoculum of 2 x 107 cells was injected s.c. and bilaterally into the flanks of 2 6-8 week-old male BALB/c athymic nude mice. After 12 days, tumours were palpable at each injection site. The growth of these tumours was monitored during the following 5 days ( Figure  2a ), after which time the animals were sacrificed by cervical dislocation and the tumours harvested. There was no evidence for invasion of tumour cells to the spleen, liver, lungs or retroperitoneal nodes.
One tumour was frozen in liquid N2 immediately, a second was dissected, examined with a panel of monoclonal antibodies and established in vitro. The majority of the viable cells (>75%) were mouse 'T' lymphocytes. This was assessed using a fluorescein-conjugated rat anti-mouse monoclonal antibody directed against murine 'T' cell surface markers. (MAS 50, Sussex) . This population produced a pure culture within 7 days and had a doubling time of 11.8h ( Figure 2b ). The cells all carried the MAS 50 'T' cell marker and had murine karyotype. Samples of the cells were examined by electron microscopy ( Figure  lb (MIT 1) had a poorly developed endoplasmic reticulum and 'C' type virus particles could be seen budding from the plasmalemma. The murine origin of this lymphoma was confirmed by chromosome analysis and compared with the original human cell line. Figure 3a , b shows that the MIT 1 cells had telocentric chromosomes, characteristic of murine origin, whereas the RPMI-8226 cells do not have this type of chromosome. In human cells chromosomes are either meta, sub-meta or acrocentric.
The two remaining tumours, one from each animal were passaged bilaterally into the flanks of a further group of 16 athymic nude mice (see Figure 4 ). Large oedematous tumours, which were palpable on day 11, grew at each injection site. Animals were sacrificed before the tumours ulcerated, and samples of tumours were harvested and dissociated. Examination of these tumour cells with monoclonal antibodies and by karyotype showed that they were also murine 'T' lymphomas.
The growth of the tumour which had been stored in liquid N2 was examined in homozygous and heterozygous immunocompetent BALB/c mice. The data summarized in Figure 4 show that tumours grew in immunocompetent animals. However it took 17 days for tumours to reach a mean diameter of 1 cm in these animals compared with 11 days in athymic nude mice. In each instance these tumours were murine 'T' lymphomas. When 5 x 106 MIT 1 cells were used an inoculum into mice of different phenotype, the time course of appearance of tumours was similar to that seen in animals which had received tumour cells from liquid N2 (see Figure 4) . Thus, each of the four tumours, which arose following the inoculation of the human cell line, RPMI-8226, into athymic nude mice, resulted from the growth of murine 'T' lymphomas.
In a second experiment, 4 female athymic nude mice were injected bilaterally in the flank with a bolus of 2 x 107 RPMI-8226 cells. Tumours appeared at two of the injection sites in separate animals 4 weeks after implantation. One of these tumours was a murine 'T' lymphoma, the second consisted of predominantly RPMI-8226 cells. The human myeloma cells were re-established in vitro. Examination of their karyotype showed that they are similar to the original cell line. Virus particles were not detectable using electron microscopy. No tumour growth occurred in the remaining two animals even though they received a further inoculation of 107 RPMI-8226 cells 4 weeks after the original injection.
The observations that all these 'T' lymphomas were of mouse karyotype, produced tumours in immune-competent animals and contained 'C' type virus particles suggests that they resulted from the activation of murine leukaemia virus MuLV by the human myeloma cell line. Gautsch et al. (1980) Figure 1 Electron micrographs of (a) (human myeloma), arrow indicates typical well-developed endoplasmic reticulum characteristic of plasma cells (x 33,000) and; (b) MIT (mouse 'T' lymphoma) arrow indicates virus particle budding from the plasmalemma (x 127,000). et al., 1982) . Although there was no evidence for metastatic spread in the experiments reported herein this may have been due to the rapid growth of the primary tumours which necessitated the termination of experiments before the tumours ulcerated. Our findings concerning the rapid growth of these tumours are in agreement with those of Sparrow et al. (1986) who pointed out that since human tumour xenografts grow relatively slowly, rapid tumour growth and skin ulceration should alert the investigator of possible malignant transformation of endogenous murine cells. The incidence of 'T' lymphomas in our system (5/6) is much higher than that reported by other workers. Sparrow et al. (1986) reported 3 murine fibrosarcomas which arose over a 6 year period from 30 human xenografts. In this respect the RPMI-8226 cell line appears more effective in initiating the production of endogenous virus which results in lynmphoma production than they are of becoming established as a xenograft. The mechanisms of this virus induction remains obscure however, it is possible that RPMI-8226 cells produce a factor or hormone that acts as a potent inducer of endogenous 'C' type virus. A similar mechanism has been proposed to account for the induction of MuLV in nude mice bearing an oat cell carcinoma xenograft (Gautsch et al., 1980) . Our results emphasize a serious pitfall that may be encountered when handling human tumour material as xenografts. Without examination of the resultant tumour cells in vitro for their growth pattern and against a panel of monoclonal antibodies directed against murine as well as human tissue any conclusion concerning the drug sensitivity of our myeloma cell line in vivo would have been meaningless. Furthermore, the data suggest that RPMI-8226 cells should be handled with caution since their ability to initiate the production of retrovirus may not be limited to viruses of murine origin.
